GENE ONLINE|News &
Opinion
Blog

AbbVie
Ranking & Reports AbbVieQ2 Report
AbbVie’s Q2 2024 Financial Highlights: Growth in Immunology, Oncology, and Neuroscience
2024-08-06
Asia-Pacific ADCManufacturingAstraZeneca
AstraZeneca’s $1.5 Billion ADC Manufacturing Facility in Singapore
2024-05-23
Manufacturing investment
AbbVie Boosts Global Manufacturing with $223 Million Expansion in Singapore
2024-01-29
Editors' Picks Healthcare Industrybiotechbiopharma
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
Trials & Approvals AbbVie
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Special Lawsuit
Dutch Pharmaceutical Watchdog Organization Sues Abbvie over Humira Pricing
2023-02-22
Trials & Approvals EMA
AbbVie and Genmab’s Joint Cancer Treatment Receives EMA Validation
2022-10-28
M&A AbbVie
AbbVie Buys DJS Antibodies For $255 Million To Beef Up Immunology Portfolio
2022-10-21
Trials & Approvals Psoriatic Arthritis
New Data Shows the Long Term Effectiveness of AbbVie’s Psoriatic Arthritis Treatment
2022-09-12
Licensing Sosei Heptares
Sosei Heptares and Abbvie Partner in Potential $1.2 Billion Neurological Disease Deal
2022-08-02
Trials & Approvals Crohn’s disease
AbbVie Scores First FDA Thumbs Up for Crohn’s Disease
2022-06-20
Licensing Autoimmune Disease
AbbVie & Cugene Join Forces to Tackle Autoimmune Diseases
2022-05-17
Deals Immunotherapy
AbbVie’s Big Moves; Expanding with One Company, Cutting Ties with Another
2022-04-21
Regulatory Overdose
Compensating for OxyContin: The Harm from Pharma
2022-04-12
Manufacturing Supply Chain
How Did the Russian Invasion of Ukraine Affect Global Biopharma?
2022-03-16
1 2
LATEST
TCELS’s Path to a Self-Sufficient Biotech Thailand: Entrepreneurs in Global Competitiveness, Raw Material Exports, and Cosmetic Innovations
2024-10-04
Lilly Invests $4.5B in Indiana Facility for In-House Clinical Manufacturing
2024-10-03
Can New GLP-1 Contenders Disrupt the Weight-Loss Giants, Lilly and Novo, in the Battle for Market Dominance?
2024-10-03
2024 Tang Prize Celebrates Revolutionary Biopharma Discoveries, a Nod to Game-Changing Diabetes and Obesity Treatments
2024-09-30
Eyes on Nvidia: A Strong Investment Prospect, Driving Billions in AI Development and Advanced Infrastructure
2024-09-30
Immunai and AstraZeneca’s $18 Million AI Collaboration to Transform Cancer Drug Development
2024-09-26
Pfizer Pulls Sickle Cell Treatment Over Deadly Complication Risks
2024-09-26
READ MORE
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-10
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
2024-10-28
BioFuture 2024
New York, U.S.A.
2024-10-30
AusBiotech 2024
Melbourne, Australia
2024-11-04
BIO-Europe 2024
Stockholm, Sweden
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top